跳至主要内容
临床试验/KCT0001388
KCT0001388尚未招募未知

Clinical study for therapeutic effect of acupuncture in patients with functional dyspepsia

Comprehensive and Integrative Medical Institute0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 70(Year)(—)
性别
All

入选标准

  • 1. Individuals between the ages of 20 and 70 years
  • 2. Individuals who meet the Rome III FD criteria:
  • 1) Patients with one or more of these symptoms (such as postprandial fullness, early satiation, or epigastric pain or burnin g) will be considered patients with dyspepsia. If patients with typical FD symptoms have heart burn, acid regurgitation, abdominal bloating, nausea, vomiting, or belching, this could not exceed at frequency of one epidode per week.
  • 2) Individuals with epigastric pain or burning more than once a week and they check more than three points on the visual analogue scale (VAS) for dyspeptic symptoms.
  • 3) Individuals with postprandial fullness or early satiation more than twice a week.
  • 3. Patients were required to have a negative upper endoscopy which excluded esophagitis, peptic ulcer disease and esophageal or gastric neoplasia. The endoscopy was required to be completed within 6 month prior to enrolment.
  • 4. Individuals who voluntarily agree with a study protocol and sign a written informed consent

排除标准

  • 1. Individuals who have peptic ulcer, erosive gastritis, acute hemorrhagic gastritis, reflux esophagitis, esophageal cancer or gastric cancer confirmed by upper GI endoscopy.
  • 2. Individuals who have had surgery related with the gastrointestinal tract, except for appendectomy and hysterectomy.
  • 3. Individuals who have serious structural gastrointestinal disease (gastrointestinal bleeding, mechanical obstruction, perforation of gastrointestinal tract) within the last two years.
  • 4. Individuals who are taking drugs which might affect the gastrointestinal tract motility and function; a minimum wash-out period of one week is required before participating in the trial.
  • 5. Individuals who have serious diseases of the cardiovascular, hepatic, renal or brain disease; prolactin secreting pituitary adenoma, liver cirrhosis, chronic renal failure, congestive heart failure.
  • 6. Individuals who are pregnant, breastfeeding or women of child bearing age who don’t do it for birth control.
  • 7. Individuals who have acute narrow-angle glaucoma, myasthenia gravis or acute myocardial infarction.
  • 8. Individuals who have active psychiatric disease or alcoholism.
  • 9. Individuals who have underweight or obesity; body mass index is less than 18 kg/m2 or more than 30 kg/m2
  • 10. Individuals with anticoagulant therapy
  • 11. Individuals with dyspeptic symptoms who received herbal medicine or acupuncture terapy in the 3 months before enrolment.
  • 12. Other exclusion criteria included patients with any clinically abnormalities, if judged inappropriate for participating this clinical trial.

研究者

发起方
Comprehensive and Integrative Medical Institute

相似试验

Clinical study for therapeutic effect of acupuncture... | 临床试验